The rational clinical examination. Does this patient have a mole or a melanoma?
暂无分享,去创建一个
[1] A. Halpern,et al. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. , 1990, Journal of the American Academy of Dermatology.
[2] B Gerbert,et al. Primary care physicians as gatekeepers in managed care. Primary care physicians' and dermatologists' skills at secondary prevention of skin cancer. , 1996, Archives of dermatology.
[3] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[4] Gary S. Rogers,et al. Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma , 1992 .
[5] C. Grin,et al. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome. , 1991, The Journal of dermatologic surgery and oncology.
[6] M. Litaker,et al. Clinical predictors of malignant pigmented lesions. A comparison of the Glasgow seven-point checklist and the American Cancer Society's ABCDs of pigmented lesions. , 1992, The Journal of dermatologic surgery and oncology.
[7] W. Clark,et al. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. , 1985, Annals of internal medicine.
[8] M. Skolnick,et al. Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia. , 1996, Journal of the American Academy of Dermatology.
[9] W. McCarthy,et al. Small-diameter malignant melanoma: a common diagnosis in New South Wales, Australia. , 1992, Journal of the American Academy of Dermatology.
[10] E. R. Farmer,et al. NIH Consensus conference. Diagnosis and treatment of early melanoma. , 1992, JAMA.
[11] R. Mcgee,et al. The recognition and management of melanoma and other skin lesions by general practitioners in New Zealand. , 1994, The New Zealand medical journal.
[12] Alfred W. Kopf,et al. Dysplastic nevi , 1989 .
[13] J. Kirkwood,et al. Interclinician agreement on the recognition of selected gross morphologic features of pigmented lesions. Studies of melanocytic nevi V. , 1992, Journal of the American Academy of Dermatology.
[14] M. Lebwohl,et al. Importance of complete cutaneous examination for the detection of malignant melanoma. , 1986, Journal of the American Academy of Dermatology.
[15] Robin Marks,et al. Early detection of skin cancer , 1994, The Medical journal of Australia.
[16] K. Welvaart,et al. Screening for skin cancer in The Netherlands. , 1991, Acta dermato-venereologica.
[17] M. G. Cook,et al. Accuracy in clinically evaluating pigmented lesions. , 1989, BMJ.
[18] A. Kopf,et al. Dysplastic nevi. Markers for increased risk for melanoma. , 1989, Cancer.
[19] M S Blois,et al. Clinical characteristics of early cutaneous melanoma , 1980, Cancer.
[20] A. Kopf,et al. Early detection of malignant melanoma: The role of physician examination and self‐examination of the skin , 1985, CA: a cancer journal for clinicians.
[21] R. MacKie,et al. Clinical recognition of early invasive malignant melanoma. , 1990, BMJ.
[22] D. Rigel,et al. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. , 1996, Journal of the American Academy of Dermatology.
[23] J. Bourke,et al. An evaluation of the revised seven‐point checklist for the early diagnosis of cutaneous malignant melanoma , 1994, The British journal of dermatology.
[24] E.M. HIGGINS,et al. The application of the seven‐point check‐list in the assessment of benign pigmented lesions , 1992, Clinical and experimental dermatology.
[25] R. Lew,et al. Who discovers melanoma? Patterns from a population-based survey. , 1992, Journal of the American Academy of Dermatology.
[26] Irene Gage,et al. Evaluation of melanoma/skin cancer screening in Massachusetts. Preliminary results , 1990, Cancer.
[27] C. Grin,et al. Accuracy in the clinical diagnosis of malignant melanoma. , 1990, Archives of dermatology.
[28] H. C. Williams,et al. How do malignant melanomas present and does this correlate with the seven‐point check‐list? , 1991, Clinical and experimental dermatology.
[29] P. Duray,et al. Usefulness of frequent skin examination for the early detection of second primary cutaneous melanoma. , 1989, Cancer detection and prevention.
[30] A. Kopf,et al. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. , 1996, Journal of the American Academy of Dermatology.
[31] E J Lusk,et al. How well do physicians recognize melanoma and other problem lesions? , 1986, Journal of the American Academy of Dermatology.
[32] J C Briggs,et al. Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.
[33] D. Ramsay,et al. The ability of primary care physicians to recognize the common dermatoses. , 1981, Archives of dermatology.
[34] D. Simel,et al. Does the clinical examination predict airflow limitation? , 1995, JAMA.
[35] M C Mihm,et al. Cutaneous malignant melanoma: Prognostic guidelines for physicians and patients , 1982, CA: a cancer journal for clinicians.
[36] A Halpern,et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. , 1997, JAMA.
[37] M Keefe,et al. A study of the value of the seven‐point checklist in distinguishing benign pigmented lesions from melanoma , 1990, Clinical and experimental dermatology.
[38] R. Stern,et al. Diagnosis and treatment of nevomelanocytic lesions of the skin. A community-based study. , 1993, Archives of dermatology.
[39] L. Hubener,et al. Malignant melanoma; a statistical review of clinical and histological diagnoses. , 1956, A.M.A. archives of dermatology.